Loading...
Market
Which department will the interim CEO of Olympus be from by December 31, 2024?
2
Resolution / Starting Odds
Finance • 25%
Operations • 25%
Research and Development • 25%
Sales and Marketing • 25%
Official Olympus press release or reputable financial news outlets
Story
Olympus CEO Resigns Following Drug Allegations; Shares Drop 6%
Oct 28, 2024, 02:21 AM
Olympus Corp., the Japanese medical equipment maker, announced that CEO Stefan Kaufmann has resigned following allegations that he purchased illegal drugs. The company conducted an investigation and found behaviors inconsistent with company policy. The resignation has caused Olympus shares to drop over 6%.
View original story
Similar markets
Internal Olympus executive • 25%
External hire • 25%
Interim CEO appointed as permanent • 25%
Other • 25%
Revenue increases • 25%
Revenue decreases • 25%
Revenue remains stable • 25%
Other • 25%
Majority of board replaced • 25%
Minor changes to board • 25%
No changes to board • 25%
Other • 25%
Boehringer Ingelheim • 25%
AstraZeneca • 25%
Another major pharmaceutical company • 25%
A biotech startup • 25%
Current interim CFO • 25%
External hire from another automaker • 25%
Internal promotion from within Nissan • 25%
Other • 25%
Muneeb Ali • 25%
Ryan Shea • 25%
New external hire • 25%
Other internal executive • 25%
Executive A • 25%
Executive B • 25%
Both • 25%
Neither • 25%
Chief Financial Officer • 25%
Chief Operating Officer • 25%
Board Member • 25%
Other • 25%
Yes, internal promotion • 25%
Yes, external hire • 25%
No change • 25%
Interim CEO appointed • 25%
Current CEO remains • 33%
New CEO appointed • 33%
Interim CEO appointed • 33%